Senderowicz Adrian 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed May 13, 2020
Insider Transaction Report
Form 4
Senderowicz Adrian
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-05-12−9,357→ 99,663 totalExercise: $5.51Exp: 2027-07-10→ Common Stock (9,357 underlying) - Exercise/Conversion
Common Stock
2020-05-12$5.51/sh+9,357$51,557→ 25,241 total - Sale
Common Stock
2020-05-12$50.18/sh−9,357$469,488→ 15,884 total
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $50.00 to $50.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021.